"These corporations have learned how to play the medical-scientific establishment like a Stradivarius," Johns Hopkins cardiology operations chief says after Moderna share price spikes. Its mRNA flu vaccine trial data are still hidden.
Trump is rolling back decades of childhood vaccine guidance by signing an executive order calling for children to be vaccinated against 11 diseases instead of the 18 currently advised by the Centers for Disease Control and Prevention. Dr. Joshua Sharfstein, distinguished professor of practice in health policy and management at Johns Hopkins Bloomberg School of Health, joins The Weeknight to explain the dangerous consequences of the executive order.
Johns Hopkins officials say they are deeply concerned about the university employee was arrested during a personal trip
Food and Drug Administration Commissioner Marty Makary is stepping down after a turbulent 13-month term marked by organizational upheaval, controversies over drug approvals and tensions with the White House. - Kyle Diamantas, the agency's deputy commissioner for food, will serve as acting commissioner, according to sources familiar. Why it matters: Under Makary, FDA became the unexpected source of drama and a lightning rod for Health Secretary Robert F. Kennedy Jr.'s broader efforts to upend health policy. - His departure means the Trump administration will be seeking to fill three Senate-confirmed health positions, including vacancies for Centers for Disease Control director and surgeon general. Driving the news: Makary, a Johns…
Dr. Amesh Adalja, senior scholar for Johns Hopkins Center for Health Security, explains the Andes variant of the hantavirus and how it spreads.
ABC News' Victor Oquendo and Dr. Darien Sutton discuss the latest updates regarding the hantavirus.
The Food and Drug Administration was supposed to be the dull and predictable part of President Trump's health bureaucracy. - Instead, it's become the soap opera whose cliffhangers leave entire industries in suspense — most recently Friday's drama over reports that commissioner Marty Makary was about to be booted out. Why it matters: The FDA regulates about one-fifth of the U.S. economy, so organizational disarray , surprise policy moves and political interference can cause real disruption. State of play: The Johns Hopkins physician and researcher appeared to have been spared late last week after multiple outlets reported that President Trump had authorized his firing. - Under Makary, there's been considerable drama around abortion…
On this episode of "On Balance," Leland Vittert takes a closer look at the war in Iran and questions what’s happening, what’s important here and where things are. President Trump has to fend off not only the Iranians and Democrats, but members of his own party as well. Brig. Gen. John Teichert joins TPUSA contributor Jack Posobiec to discuss. Meanwhile, skyrocketing gas prices continue to put pressure on Americans as the war continues. While ending the war with Iran would help, it’s not the only way to get relief and reduce costs. Losing regulations and lowering gas taxes are possible solutions that politicians seem to ignore. Jillian Michaels, host of the “Keeping It Real” podcast, analyzes. Later, this week's Indiana state…
Researchers from Johns Hopkins, Oxford, Stanford, Columbia and NYU are calling for guardrails on certain infectious disease datasets that could enable AI to design deadly viruses . Why it matters: Once high-risk biological data hits the open web, it can't be recalled — and regulation won't matter if the knowledge itself is already widely distributed. Driving the news: An international group of more than 100 researchers has endorsed a framework to govern certain biological data the same way we handle sensitive health records. - The debate comes as the Trump administration pushes an aggressive "move fast" AI agenda. - The White House's Genesis Mission — announced in late 2025 — aims to build AI systems trained on massive scientific…